The FDA approved a supplemental new drug application for Ryzumvi, a preservative-free eye drop, for the treatment of ...
The FDA approved Brytly, a nonprescription eye drop for the relief of eye redness from minor irritations, according to a ...
The FDA approved Enspryng, an interleukin-6 inhibitor, for at-home subcutaneous treatment of thyroid eye disease, according ...
Every year, the behavioral health industry gathers at Behavioral Health Tech, one of the largest meetings of its kind.It is ...
Body roundness index may improve mortality risk stratification in metabolic dysfunction-associated steatotic liver disease, ...
A classification system specific to fracture-related infections captured more cases of infection than the CDC surgical site ...
Fecal immunochemical tests appear more sensitive to colorectal cancer and advanced precancerous lesions in men than women, ...
The FDA has cleared an automated insulin delivery system for adults with type 2 diabetes who are treated with insulin, ...
The risk for mortality and gastrointestinal/serious hemorrhage among Winrevair recipients did not differ between those with ...
A multicenter cohort analysis revealed that more than 1 in 10 healthcare workers in the United States endure ...
Anti-VEGF injections before cataract surgery may protect eyes with retinal vein occlusion from developing postoperative ...
Bausch + Lomb and Bausch Health Companies announced Oct. 12 that Thomas J. Appio was named interim CEO, taking over the role ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results